TY  - GEN
AU  - Shin,D M
AU  - Holoye,P Y
AU  - Murphy,W K
AU  - Forman,A
AU  - Papasozomenos,S C
AU  - Hong,W K
AU  - Raber,M
TI  - Phase I/II clinical trial of didemnin B in non-small-cell lung cancer: neuromuscular toxicity is dose-limiting
SN  - 0344-5704
PY  - 1992///0207
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Depsipeptides
KW  - Drug Administration Schedule
KW  - Drug Evaluation
KW  - Female
KW  - Humans
KW  - Infusions, Intravenous
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Muscles
KW  - drug effects
KW  - Neuromuscular Junction
KW  - Peptides, Cyclic
N1  - Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1007/BF00687325
ER  -